281 related articles for article (PubMed ID: 12101115)
1. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes.
Xu J; Meyers DA; Sterling DA; Zheng SL; Catalona WJ; Cramer SD; Bleecker ER; Ohar J
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):664-9. PubMed ID: 12101115
[TBL] [Abstract][Full Text] [Related]
2. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort.
Xue WM; Coetzee GA; Ross RK; Irvine R; Kolonel L; Henderson BE; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):575-9. PubMed ID: 11401905
[TBL] [Abstract][Full Text] [Related]
3. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
[TBL] [Abstract][Full Text] [Related]
4. Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?
Mittal RD; Mishra DK; Thangaraj K; Singh R; Mandhani A
Steroids; 2007 Apr; 72(4):335-41. PubMed ID: 17257635
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive assessment of candidate genes and serological markers for the detection of prostate cancer.
Nam RK; Zhang WW; Trachtenberg J; Jewett MA; Emami M; Vesprini D; Chu W; Ho M; Sweet J; Evans A; Toi A; Pollak M; Narod SA
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1429-37. PubMed ID: 14693733
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the AR and PSA genes as markers of susceptibility and aggressiveness in prostate cancer.
Kuasne H; Rodrigues IS; Fuganti PE; Losi-Guembarovski R; Ito K; Kishima MO; Rodrigues MA; Rogatto SR; Santos RM; Cólus IM
Cancer Invest; 2010 Nov; 28(9):917-24. PubMed ID: 20632874
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the androgen receptor and the prostate-specific antigen genes and prostate cancer risk.
Salinas CA; Austin MA; Ostrander EO; Stanford JL
Prostate; 2005 Sep; 65(1):58-65. PubMed ID: 15810021
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci.
Xue W; Irvine RA; Yu MC; Ross RK; Coetzee GA; Ingles SA
Cancer Res; 2000 Feb; 60(4):839-41. PubMed ID: 10706090
[TBL] [Abstract][Full Text] [Related]
9. Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells.
Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Carvalho R; Lopes C
Prostate; 2002 Sep; 53(1):88-94. PubMed ID: 12210484
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.
Binnie MC; Alexander FE; Heald C; Habib FK
Prostate; 2005 Jun; 63(4):309-15. PubMed ID: 15599941
[TBL] [Abstract][Full Text] [Related]
11. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms within androgen receptor, 5alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.
Schatzl G; Madersbacher S; Gsur A; Preyer M; Haidinger G; Haitel A; Vutuc C; Micksche M; Marberger M
Prostate; 2002 Jul; 52(2):130-8. PubMed ID: 12111704
[TBL] [Abstract][Full Text] [Related]
13. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
14. Novel polymorphisms in prostate specific antigen gene and its association with prostate cancer.
Yang Q; Shan L; Segawa N; Nakamura M; Nakamura Y; Mori I; Sakurai T; Kakudo K
Anticancer Res; 2001; 21(1A):197-200. PubMed ID: 11299734
[TBL] [Abstract][Full Text] [Related]
15. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
16. Polymorphism in ARE-I region of prostate-specific antigen gene associated with low serum testosterone level and high-grade prostate cancer.
Schatzl G; Marberger M; Remzi M; Grösser P; Unterlechner J; Haidinger G; Zidek T; Preyer M; Micksche M; Gsur A
Urology; 2005 Jun; 65(6):1141-5. PubMed ID: 15893813
[TBL] [Abstract][Full Text] [Related]
17. Shorter CAG repeats in androgen receptor and non-GG genotypes in prostate-specific antigen loci are associated with decreased risk of benign prostatic hyperplasia and prostate cancer.
Das K; Cheah PY; Lim PL; Zain YB; Stephanie FC; Zhao Y; Cheng C; Lau W
Cancer Lett; 2008 Sep; 268(2):340-7. PubMed ID: 18495332
[TBL] [Abstract][Full Text] [Related]
18. Genotyping of AR and PSA polymorphisms in a patient with Klinefelter syndrome, non-Hodgkin lymphoma, and adenocarcinoma of the prostate.
Mattos Dos Santos R; Aparecida Rainho C; Carlos Souza Trindade J; Carlos Souza Trindade Filho J; Lauro Viana De Camargo J; Regina Rogatto S
Cancer Genet Cytogenet; 2004 Sep; 153(2):165-9. PubMed ID: 15350307
[TBL] [Abstract][Full Text] [Related]
19. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer.
Schatzl G; Madersbacher S; Haitel A; Gsur A; Preyer M; Haidinger G; Gassner C; Ochsner M; Marberger M
J Urol; 2003 Apr; 169(4):1312-5. PubMed ID: 12629350
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effects of androgen receptor gene trinucleotide repeats and prostate-specific antigen gene polymorphisms on prostate cancer.
Alptekin D; Izmirli M; Bayazit Y; Luleyap HU; Yilmaz MB; Soyupak B; Erkoc MA; Tansug Z
Genet Mol Res; 2012 May; 11(2):1424-32. PubMed ID: 22653589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]